SARS-CoV-2使,

Takeshi Ishikawa1, Kenji Matsumoto1, Toshiyuki Hamada2

  • 1Department of Chemistry, Biotechnology, and Chemical Engineering, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto, Kagoshima 890-0065, Japan.

概括

研究人员发现了SARS-CoV-2的主要蛋白酶 (Mpro) 的新型抑制剂,这是COVID-19治疗的关键目标. 计算方法确定了BP-1-102,它显著抑制Mpro,其基团对这种活性至关重要.